GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » EV-to-Revenue

Samsung BioLogics Co (XKRX:207940) EV-to-Revenue : 14.89 (As of May. 03, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Samsung BioLogics Co's enterprise value is ₩55,012,907 Mil. Samsung BioLogics Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,694,589 Mil. Therefore, Samsung BioLogics Co's EV-to-Revenue for today is 14.89.

The historical rank and industry rank for Samsung BioLogics Co's EV-to-Revenue or its related term are showing as below:

XKRX:207940' s EV-to-Revenue Range Over the Past 10 Years
Min: 14.06   Med: 41.52   Max: 77.93
Current: 14.89

During the past 10 years, the highest EV-to-Revenue of Samsung BioLogics Co was 77.93. The lowest was 14.06. And the median was 41.52.

XKRX:207940's EV-to-Revenue is ranked worse than
63.19% of 1035 companies
in the Biotechnology industry
Industry Median: 8.07 vs XKRX:207940: 14.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-03), Samsung BioLogics Co's stock price is ₩771000.00. Samsung BioLogics Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩51,911.16. Therefore, Samsung BioLogics Co's PS Ratio for today is 14.85.


Samsung BioLogics Co EV-to-Revenue Historical Data

The historical data trend for Samsung BioLogics Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co EV-to-Revenue Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.78 46.86 38.05 19.24 14.60

Samsung BioLogics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.24 17.31 15.60 13.62 14.60

Competitive Comparison of Samsung BioLogics Co's EV-to-Revenue

For the Biotechnology subindustry, Samsung BioLogics Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung BioLogics Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Samsung BioLogics Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Samsung BioLogics Co's EV-to-Revenue falls into.



Samsung BioLogics Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Samsung BioLogics Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=55012906.888/3694588.767
=14.89

Samsung BioLogics Co's current Enterprise Value is ₩55,012,907 Mil.
Samsung BioLogics Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,694,589 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samsung BioLogics Co  (XKRX:207940) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Samsung BioLogics Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=771000.00/51911.155
=14.85

Samsung BioLogics Co's share price for today is ₩771000.00.
Samsung BioLogics Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩51,911.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samsung BioLogics Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co (XKRX:207940) Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines